CRESTLINE MANAGEMENT, LP – United Therapeutics Corporation Transaction History
CRESTLINE MANAGEMENT, LP portfolio value:
$2.55M
portfolio value
CRESTLINE MANAGEMENT, LP quarter portfolio value change:
-11.14%
quarter
United Therapeutics Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +72.58% | 5.12K shares | 887K | $209.38 | 12.18K |
| Q2 2022 | share | Decrease | -18.49% | -1.60K shares | 109K | $235.64 | 7.05K |
| Q1 2022 | share | Decrease | -57.25% | -11.59K shares | -2.82M | $179.41 | 8.65K |
| Q4 2021 | share | Increase | +17.48% | 3.01K shares | 1.19M | $215.18 | 20.25K |
| Q3 2021 | share | Increase | +53.19% | 5.98K shares | 1.16M | $184.58 | 17.24K |
| Q2 2021 | share | Increase | 0.00% | 11.25K shares | 2.01M | $179.41 | 11.25K |
| Q4 2019 | share | Decrease | -100.00% | -37.5K shares | -2.99M | $88.08 | 0 |
| Q3 2019 | share | Increase | +188.46% | 24.5K shares | 1.97M | $79.75 | 37.5K |
| Q2 2019 | share | Increase | 0.00% | 13K shares | 1.01M | $78.06 | 13K |